Medicine

All Articles

Prenatal exposure to destitution impacts long term wellness

.Nature Medication, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of d...

An international metric of invulnerable wellness

.Attributes Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A study u...

Niacin, meals consumption and cardio effects

.Nature Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, meals...

Opportunities and also challenges for patient-reported outcome examination in multimorbidity research study and method

.Completing rate of interests.S.E.H. acquires financing from the National Principle of Health and Ca...

Hibernation scientific research utilized to deal with obesity and modify metabolic process

.Attributes Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy comprehendi...

CAR- T and cellular genetics treatments are actually as well pricey

.Mother Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-ca...

The that genomics program of work with equitable execution of individual genomics for international health and wellness

.The magazine of the first draft of the individual genome sequence in 20011 was actually observed by...

A time-stratified, case\u00e2 $ \"crossover research of warmth direct exposure and perinatal mortality coming from 16 healthcare facilities in sub-Saharan Africa

.Among 138,015 hospital-based singleton births in 4 sub-Saharan African countries, our company obser...

Advancing international antibiotic investigation, growth and gain access to #.\n\nMurray, C. J. L. et cetera. International burden of microbial antimicrobial resistance in 2019: a methodical analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. Towards particular dedications and also activity in the feedback to antimicrobial resistance. Global Frontrunners Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Wellness Organization. WHO posts checklist of micro-organisms for which new antibiotics are actually urgently needed. World Health and wellness Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Association. WHO bacterial concern virus listing, 2024: microbial virus of public health value to direct research study, progression and also tactics to prevent as well as handle antimicrobial resistance. Globe Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nWorld Wellness Association. 2023 antibacterial representatives in clinical and also preclinical development: a guide and analysis. World Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Evaluation. May 19, 2016 \u00e2 $\" Addressing drug-resistant infections around the world: final document and suggestions. Evaluation on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: reports as well as briefing. Steer AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall surface: a require collective activity on antibiotics r &amp d. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Short 51: Just how can the EU support maintainable advancement and also accessibility to successful antibiotics? policy alternatives for existing as well as brand new medications. European Observatory on Health Solutions and also Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic usage and also resistance\u00e2 $\" confirming the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Association. 2021 Informed distinction. WHO access, view, get, distinction of antibiotics for assessment and also tracking of use. Globe Health Company https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Facility for Health Condition Avoidance and Control. Antimicrobial resistance targets: exactly how can our company reach them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Association. Lack of technology set to threaten antibiotic functionality and wellness gains. Globe Wellness Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial resistance is linked to environment improvement: a summary of pair of entwined global problems. Int. J. Environ. Res. Hygienics 20, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: our company require emergency action as well as financial investment that concentrate on the weakest link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Association. Booster shot coverage. Globe Health Organization https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination deterrence and command in low-resource setups: the requirement for the local area, the contextual as well as the practical. Contaminate. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Difficulties of executing antimicrobial conservation devices in low to mid profit nations (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A quick record of the antibiotic age: lessons found out and also problems for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et cetera. Patient access in 14 high-income nations to new antibacterials authorized due to the US Fda, European Medicines Agency, Japanese Pharmaceuticals and Medical Instruments Firm, or even Health Canada, 2010\u00e2 $ \"2020. Clin. Infect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health Organization. 2021 antibacterial agents in medical as well as preclinical development: an outline and also evaluation. World Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the economics should support the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of innovation in antibacterial therapeutics. Medical Technology Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Determining specialist use of next-generation anti-biotics versus immune Gram-negative infections in united state health centers: a retrospective accomplice research. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of innovation in antibacterial rehabs. Medical Advancement Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical review and vital assessment of motivation tactics for revelation and also growth of unfamiliar anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nWellness Unexpected Emergency Preparedness and Reaction Authorization. Trial and error of health care countermeasures. International Payment https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Percentage. Pre-draft proposal for an International relationship under Perspective Europe One Wellness Antimicrobial Protection. European Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Worldwide Antibiotic R &amp D Partnership. Entasis Therapeutics and the Global Antibiotic Analysis &amp Progression Collaboration to create a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of industry- and non-industry-sponsored professional tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Organization. Number of clinical test enrollments by site, health condition, period of growth, grow older as well as sex of test individuals (1999\u00e2 $ \"2022). World Wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Prescription Antibiotic R &amp D Alliance. NeoSept1: a research to find out the position of existing as well as brand-new prescription antibiotics combinations to manage newborns that remain in health center with extreme sepsis. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Firm of Canada. Government of Canada brings in vital expenditure to eliminate antimicrobial protection (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Worldwide Prescription Antibiotic Trial And Error Alliance. Asia federal government financing sustains GARDP\u00e2 $ s attempts to counter antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Base. Novo Nordisk Base partners along with CARB-X to fight drug-resistant diseases. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Health and Digital Exec Firm. Research study on taking AMR medical countermeasures to the market. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the necessary size of global pull rewards for anti-bacterial medications. Wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimension a market access perks for the progression of brand new prescription antibiotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Business rewards and also antibiotic resistance: an introduction to the antibiotic sensitivity bonus offer. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG evolved devotion for subscription-based purchasing of novel antimicrobials as well as its expected return on investment. Facility for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in brand new prescription antibiotics would settle \u00e2 $\" for every person. Workplace of Health and wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up battle versus dangerous infections following successful world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Compensation versions to tackle market failures for antimicrobials: methods consumed France, Germany, Sweden, the UK, and the United States. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Federation of Drug Manufacturers and Affiliations. Coming from resistance to durability: what could the potential antibiotic pipe appear like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Hub &amp Planet Wellness Institution. Incentivising the progression of brand new antibacterial treatments: 2023 progress report due to the Worldwide AMR R&ampD Hub and also WHO. Global AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK subscription style for anti-biotics considered successful? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" novel stimuli for the progression as well as continuing the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, local, and also national causes of kid death in 2000\u00e2 $ \"thirteen, along with estimates to inform post-2015 concerns: an improved step-by-step study. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et cetera. Anti-bacterial drug lacks from 2001 to 2013: implications for professional exercise. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French reporting body for drug shortages: summary and also fads from 2012 to 2018: an observational retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Analysis of that antibiotic intake and also accessibility intendeds in 76 countries, 2000\u00e2 $ \"15: an evaluation of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the fakes: tackling substandard and also falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring simpler to secure anti-biotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nAfrican Culture for Lab Medicine. Policy concise as well as infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for human use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Corrupt. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial intake: evaluation of central stockrooms materials to in-patient treatment wellness centers coming from 2017 to 2019 in Uganda. Trop. Medication. Infect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Variations in the usage of antimicrobial medicines in the European region, 2014\u00e2 $ \"2018: searchings for and also ramifications coming from ESAC-Net as well as WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Medicine scarcity: sources, impact, as well as mitigation tactics. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual gain access to in 14 high-income nations to new antibacterials authorized due to the US Fda, European Medicines Agency, Japanese Pharmaceuticals and Medical Tools Organization, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Wasted anti-biotics: a follow-up stock research in Europe, the U.S.A., Canada as well as Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness development for international health. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Industry Partnership. The 2023 AMR Industry Partnership development study: production and the atmosphere. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can health care items be built on a charitable basis? Checking out item progression relationships for ignored health conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the worldwide public interest. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Disease Control and also Avoidance. Africa CDC pioneers bold move to protect Africa\u00e2 $ s health and wellness future by creating a 50 billion buck clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Haggling public-health trademark licensing agreements to increase access to health innovations: an insider\u00e2 $ s story. BMJ Chunk. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service designs for experimentation with affordability criteria are needed to have to accomplish fair costs of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator. Stewardship and access. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Anti-biotic Research and Development Relationship. Shinogi, GARDP as well as CHAI introduce site certificate and cooperation agreements to alleviate microbial infections next to broadening access to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Collaboration. Leaving behind the laboratory: tracking the decline in AMR R&ampD specialists. amr Market Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 phone call to activity on antimicrobial resistance. G7G20 Papers Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Coalition on Growing Old &amp Transmittable Illness Society of The United States. 2024 AMR readiness mark report card. Determining authorities activity on AMR policy. Worldwide Coalition on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and Horticulture Organization of the United Nations, United Nations Atmosphere Program, World Wellness Company &amp. Globe Organization for Creature Wellness. International data bank for tracking antimicrobial resistance (AMR): nation self-assessment poll (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...

Integrating liver endpoints in professional tests of heart as well as renal ailment

.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Poin...